Previous Article | Next Article 
J Clin Microbiol. 1985 July; 22(1): 5-8
Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis.
P H Gilligan,
P A Gage,
L M Bradshaw,
D V Schidlow and
B T DeCicco
ABSTRACT
A new medium for the isolation of Pseudomonas cepacia from respiratory tract secretions of patients with cystic fibrosis (CF) is described. This medium consists of inorganic salts, 0.5% pyruvate, and 0.1% proteose peptone as nutritive components and 0.0001% crystal violet, 0.15% bile salts, 100 micrograms of ticarcillin per ml, and 300 U of polymyxin B per ml as selective agents. The medium, designated PC medium, supported superior growth of 38 of 50 stock isolates of P. cepacia after 48 h of incubation when compared with MacConkey agar (0 of 50). The medium completely inhibited the growth of 112 of 124 stock isolates of organisms commonly found in respiratory secretions of CF patients. Cultures were made on PC medium with respiratory secretions of 169 CF patients. P. cepacia was recovered from 35 patients with isolates on PC medium but from only 21 patients with isolates on MacConkey agar. Of 221 other potentially pathogenic isolates found in these specimens, only six (two Pseudomonas aeruginosa isolates, two molds, one yeast, and one Serratia marcescens isolate) grew on PC medium. PC medium should facilitate the recovery of P. cepacia from CF patients.
J Clin Microbiol. 1985 July; 22(1): 5-8
This article has been cited by other articles:
-
Zhou, J., Garber, E., Desai, M., Saiman, L.
(2006). Compliance of Clinical Microbiology Laboratories in the United States with Current Recommendations for Processing Respiratory Tract Specimens from Patients with Cystic Fibrosis. J. Clin. Microbiol.
44: 1547-1549
[Abstract]
[Full Text]
-
Chiron, R., Marchandin, H., Counil, F., Jumas-Bilak, E., Freydiere, A.-M., Bellon, G., Husson, M.-O., Turck, D., Bremont, F., Chabanon, G., Segonds, C.
(2005). Clinical and Microbiological Features of Inquilinus sp. Isolates from Five Patients with Cystic Fibrosis. J. Clin. Microbiol.
43: 3938-3943
[Abstract]
[Full Text]
-
Muhlebach, M. S., Noah, T. L.
(2002). Endotoxin Activity and Inflammatory Markers in the Airways of Young Patients with Cystic Fibrosis. Am. J. Respir. Crit. Care Med.
165: 911-915
[Abstract]
[Full Text]
-
Coenye, T., Vandamme, P., Govan, J. R. W., LiPuma, J. J.
(2001). Taxonomy and Identification of the Burkholderia cepacia Complex. J. Clin. Microbiol.
39: 3427-3436
[Full Text]
-
Malasig, M. D., Goswami, P. R., Crawford-Miksza, L. K., Schnurr, D. P., Gray, G. C.
(2001). Simplified Microneutralization Test for Serotyping Adenovirus Isolates. J. Clin. Microbiol.
39: 2984-2986
[Abstract]
[Full Text]
-
MUHLEBACH, M. S., STEWART, P. W., LEIGH, M. W., NOAH, T. L.
(1999). Quantitation of Inflammatory Responses to Bacteria in Young Cystic Fibrosis and Control Patients. Am. J. Respir. Crit. Care Med.
160: 186-191
[Abstract]
[Full Text]
-
Bauernfeind, A., Schneider, I., Jungwirth, R., Roller, C.
(1999). Discrimination of Burkholderia multivorans and Burkholderia vietnamiensis from Burkholderia cepacia Genomovars I, III, and IV by PCR. J. Clin. Microbiol.
37: 1335-1339
[Abstract]
[Full Text]
-
Henry, D., Campbell, M., McGimpsey, C., Clarke, A., Louden, L., Burns, J. L., Roe, M. H., Vandamme, P., Speert, D.
(1999). Comparison of Isolation Media for Recovery of Burkholderia cepacia Complex from Respiratory Secretions of Patients with Cystic Fibrosis. J. Clin. Microbiol.
37: 1004-1007
[Abstract]
[Full Text]
Copyright © 1985 by the American Society for Microbiology. All rights reserved.